GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2125-2132
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume36
Issue number10
DOIs
Publication statusPublished - Oct 2016

Cite this